Research Roundup

old bulbs with a smart bulb in middle
Debbie Rigby rounds up the latest in research news Is it time to move away from short-acting beta-agonists in asthma management? Evidence suggests that short-acting beta-agonist (SABAs) inhalers continue to be responsible for high levels of poorly controlled asthma and even asthma deaths. Increased SABA use at the time of worsening asthma symptoms leads to

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous The right formula
Next Doctor struck off over assault